Publication | Closed Access

Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: A perspective from the Hunter Outcome Survey (HOS)

Idursulfase TherapyClinical EpidemiologyHunter Outcome SurveyMedicineHunter Syndrome